Margaret H. Baron
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Margaret H. Baron has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Stuart T. Fraser
Disciplines of Physiology, Anatomy & Histology, School of Medical Sciences, University of Sydney, Sydney, Australia
13 shared publications - Joan Isern
Centro Nacional de Investigaciones Cardiovasculares (CNIC) Carlos III, Madrid, Spain
7 shared publications Jeffrey Barminko
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
4 shared publicationsKenneth E. Sahr
Department of Medicine (Division of Hematology and Medical Oncology), The Icahn School of Medicine at Mount Sinai, New York, NY, USA
4 shared publicationsAndrei M. Vacaru
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
3 shared publications- Anna-Katerina Hadjantonakis
Developmental Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
3 shared publications
Latest Publications
- Open Access
- 27 February 2025
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (7)
A study of MD-PhD pre-health advising identifies challenges to building a robust MD-PhD applicant pool
MD-PhD programs provide interdisciplinary training in medicine and research. Undergraduate pre-health advisors (PHAs) play a critical role in counseling prospective applicants, yet there have been no studies to our knowledge of MD-PhD pre-health advising. Here we surveyed 280 PHAs from US colleges and universities using both qualitative and quantitative measures that assessed their real-world advising behaviors as well as standardized evaluation of 1 of 2 fictional MD-PhD applicants, identical except for gender. We identified 3 factors that influenced advising behaviors: experience advising MD-PhD applicants, attitudes toward MD-PhD programs, and gender bias. Those PHAs with less experience and who held negative attitudes toward MD-PhD programs were less likely to initiate discussions about MD-PhD programs with qualified applicants and less likely to recommend the fictional applicants apply to MD-PhD programs. Finally, there was subtle gender bias that favored the male applicant. PHAs face challenges in advising MD-PhD applicants because there are relatively few MD-PHD applicants overall and there is a lack of resources to guide them. Addressing these challenges by strengthening collaborations with PHAs and providing comprehensive information about the value of and applicant qualifications for MD-PhD programs is crucial to enhancing MD-PhD advising, mitigating effects of bias, and expanding the pool of qualified applicants.
- 27 February 2025
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (7)
Open AccessA study of MD-PhD pre-health advising identifies challenges to building a robust MD-PhD applicant pool
MD-PhD programs provide interdisciplinary training in medicine and research. Undergraduate pre-health advisors (PHAs) play a critical role in counseling prospective applicants, yet there have been no studies to our knowledge of MD-PhD pre-health advising. Here we surveyed 280 PHAs from US colleges and universities using both qualitative and quantitative measures that assessed their real-world advising behaviors as well as standardized evaluation of 1 of 2 fictional MD-PhD applicants, identical except for gender. We identified 3 factors that influenced advising behaviors: experience advising MD-PhD applicants, attitudes toward MD-PhD programs, and gender bias. Those PHAs with less experience and who held negative attitudes toward MD-PhD programs were less likely to initiate discussions about MD-PhD programs with qualified applicants and less likely to recommend the fictional applicants apply to MD-PhD programs. Finally, there was subtle gender bias that favored the male applicant. PHAs face challenges in advising MD-PhD applicants because there are relatively few MD-PHD applicants overall and there is a lack of resources to guide them. Addressing these challenges by strengthening collaborations with PHAs and providing comprehensive information about the value of and applicant qualifications for MD-PhD programs is crucial to enhancing MD-PhD advising, mitigating effects of bias, and expanding the pool of qualified applicants.
- 20 February 2021
- Published by Springer Nature
- Vol. 2224, 153-182
Generation of Transgenic Fluorescent Reporter Lines for Studying Hematopoietic Development in the Mouse
Hematopoiesis in the mouse and other mammals occurs in several waves and arises from distinct anatomic sites. Transgenic mice expressing fluorescent reporter proteins at various points in the hematopoietic hierarchy, from hematopoietic stem cell to more restricted progenitors to each of the final differentiated cell types, have provided valuable tools for tagging, tracking, and isolating these cells. In this chapter, we discuss general considerations in designing a transgene, survey available fluorescent probes, and describe methods for confirming and analyzing transgene expression in the hematopoietic tissues of the embryo, fetus, and postnatal/adult animal.
- 20 February 2021
- Published by Springer Nature
- Vol. 2224, 153-182
Generation of Transgenic Fluorescent Reporter Lines for Studying Hematopoietic Development in the Mouse
Hematopoiesis in the mouse and other mammals occurs in several waves and arises from distinct anatomic sites. Transgenic mice expressing fluorescent reporter proteins at various points in the hematopoietic hierarchy, from hematopoietic stem cell to more restricted progenitors to each of the final differentiated cell types, have provided valuable tools for tagging, tracking, and isolating these cells. In this chapter, we discuss general considerations in designing a transgene, survey available fluorescent probes, and describe methods for confirming and analyzing transgene expression in the hematopoietic tissues of the embryo, fetus, and postnatal/adult animal.
- Open Access
- 29 May 2018
- Published by American Society of Hematology in Blood Advances
- Vol. 2 (11) , 1207-1219
Activation of the vitamin D receptor transcription factor stimulates the growth of definitive erythroid progenitors
Key Points: Activation of the Vdr pathway stimulates proliferation of early, but not late, mouse erythroid progenitors in a cell autonomous manner. Vdr and Gr signaling cooperate to increase the growth of mouse erythroid progenitors.
- 29 May 2018
- Published by American Society of Hematology in Blood Advances
- Vol. 2 (11) , 1207-1219
Open AccessActivation of the vitamin D receptor transcription factor stimulates the growth of definitive erythroid progenitors
Key Points: Activation of the Vdr pathway stimulates proliferation of early, but not late, mouse erythroid progenitors in a cell autonomous manner. Vdr and Gr signaling cooperate to increase the growth of mouse erythroid progenitors.
- 1 May 2016
- Published by Elsevier in Developmental & Comparative Immunology
- Vol. 58, 18-29
Development and differentiation of the erythroid lineage in mammals
- 1 May 2016
- Published by Elsevier in Developmental & Comparative Immunology
- Vol. 58, 18-29
Development and differentiation of the erythroid lineage in mammals
- 1 March 2016
- Published by Elsevier in Developmental Cell
- Vol. 36 (5) , 481-482
Chromatin Condensation and Enucleation in Red Blood Cells: An Open Question
- 1 March 2016
- Published by Elsevier in Developmental Cell
- Vol. 36 (5) , 481-482
Chromatin Condensation and Enucleation in Red Blood Cells: An Open Question
- Open Access
- 3 July 2014
- Published by Springer Nature
- Vol. 1194, 289-312
Generation of Transgenic Mouse Fluorescent Reporter Lines for Studying Hematopoietic Development
During the development of the hematopoietic system, at least eight distinct lineages are generated in the mouse embryo. Transgenic mice expressing fluorescent proteins at various points in the hematopoietic hierarchy, from hematopoietic stem cell to multipotent progenitors to each of the final differentiated cell types, have provided valuable tools for tagging, tracking, and isolating these cells. In this chapter, we discuss general considerations in designing a transgene and survey available fluorescent probes and methods for confirming and analyzing transgene expression in the hematopoietic systems of the embryo, fetus, and postnatal/adult animal.
- 3 July 2014
- Published by Springer Nature
- Vol. 1194, 289-312
Open AccessGeneration of Transgenic Mouse Fluorescent Reporter Lines for Studying Hematopoietic Development
During the development of the hematopoietic system, at least eight distinct lineages are generated in the mouse embryo. Transgenic mice expressing fluorescent proteins at various points in the hematopoietic hierarchy, from hematopoietic stem cell to multipotent progenitors to each of the final differentiated cell types, have provided valuable tools for tagging, tracking, and isolating these cells. In this chapter, we discuss general considerations in designing a transgene and survey available fluorescent probes and methods for confirming and analyzing transgene expression in the hematopoietic systems of the embryo, fetus, and postnatal/adult animal.
A conditional mutant allele for analysis of Mixl1 function in the mouse
Summary: Mixl1 is the only member of the Mix/Bix homeobox gene family identified in mammals. During mouse embryogenesis, Mixl1 is first expressed at embryonic day (E)5.5 in cells of the visceral endoderm (VE). At the time of gastrulation, Mixl1 expression is detected in the vicinity of the primitive streak. Mixl1 is expressed in cells located within the primitive streak, in nascent mesoderm cells exiting the primitive streak, and in posterior VE overlying the primitive streak. Genetic ablation of Mixl1 in mice has revealed its crucial role in mesoderm and endoderm cell specification and tissue morphogenesis during early embryonic development. However, the early lethality of the constitutive Mixl1−/− mutant precludes the study of its role at later stages of embryogenesis and in adult mice. To circumvent this limitation, we have generated a conditional Mixl1 allele (Mixl1cKO) that permits temporal as well as spatial control of gene ablation. Animals homozygous for the Mixl1cKO conditional allele were viable and fertile. Mixl1KO/KO embryos generated by crossing of Mixl1cKO/cKO mice with Sox2‐Cre or EIIa‐Cre transgenic mice were embryonic lethal at early somite stages. By contrast to wild‐type embryos, Mixl1KO/KO embryos contained no detectable Mixl1, validating the Mixl1cKO as a protein null after Cre‐mediated excision. Mixl1KO/KO embryos resembled the previously reported Mixl1−/− mutant phenotype. Therefore, the Mixl1 cKO allele provides a tool for investigating the temporal and tissue‐specific requirements for Mixl1 in the mouse. genesis 52:417–423, 2014.
A conditional mutant allele for analysis of Mixl1 function in the mouse
Summary: Mixl1 is the only member of the Mix/Bix homeobox gene family identified in mammals. During mouse embryogenesis, Mixl1 is first expressed at embryonic day (E)5.5 in cells of the visceral endoderm (VE). At the time of gastrulation, Mixl1 expression is detected in the vicinity of the primitive streak. Mixl1 is expressed in cells located within the primitive streak, in nascent mesoderm cells exiting the primitive streak, and in posterior VE overlying the primitive streak. Genetic ablation of Mixl1 in mice has revealed its crucial role in mesoderm and endoderm cell specification and tissue morphogenesis during early embryonic development. However, the early lethality of the constitutive Mixl1−/− mutant precludes the study of its role at later stages of embryogenesis and in adult mice. To circumvent this limitation, we have generated a conditional Mixl1 allele (Mixl1cKO) that permits temporal as well as spatial control of gene ablation. Animals homozygous for the Mixl1cKO conditional allele were viable and fertile. Mixl1KO/KO embryos generated by crossing of Mixl1cKO/cKO mice with Sox2‐Cre or EIIa‐Cre transgenic mice were embryonic lethal at early somite stages. By contrast to wild‐type embryos, Mixl1KO/KO embryos contained no detectable Mixl1, validating the Mixl1cKO as a protein null after Cre‐mediated excision. Mixl1KO/KO embryos resembled the previously reported Mixl1−/− mutant phenotype. Therefore, the Mixl1 cKO allele provides a tool for investigating the temporal and tissue‐specific requirements for Mixl1 in the mouse. genesis 52:417–423, 2014.
- Open Access
- 1 January 2014
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 32 (1) , 191-203
Expression of Podocalyxin Separates the Hematopoietic and Vascular Potentials of Mouse Embryonic Stem Cell-Derived Mesoderm
In the mouse embryo and differentiating embryonic stem cells, the hematopoietic, endothelial, and cardiomyocyte lineages are derived from Flk1+ mesodermal progenitors. Here, we report that surface expression of Podocalyxin (Podxl), a member of the CD34 family of sialomucins, can be used to subdivide the Flk1+ cells in differentiating embryoid bodies at day 4.75 into populations that develop into distinct mesodermal lineages. Definitive hematopoietic potential was restricted to the Flk1+Podxl+ population, while the Flk1-negative Podxl+ population displayed only primitive erythroid potential. The Flk1+Podxl-negative population contained endothelial cells and cardiomyocyte potential. Podxl expression distinguishes Flk1+ mesoderm populations in mouse embryos at days 7.5, 8.5, and 9.5 and is a marker of progenitor stage primitive erythroblasts. These findings identify Podxl as a useful tool for separating distinct mesodermal lineages. Stem Cells 2014;32:191–203
- 1 January 2014
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 32 (1) , 191-203
Open AccessExpression of Podocalyxin Separates the Hematopoietic and Vascular Potentials of Mouse Embryonic Stem Cell-Derived Mesoderm
In the mouse embryo and differentiating embryonic stem cells, the hematopoietic, endothelial, and cardiomyocyte lineages are derived from Flk1+ mesodermal progenitors. Here, we report that surface expression of Podocalyxin (Podxl), a member of the CD34 family of sialomucins, can be used to subdivide the Flk1+ cells in differentiating embryoid bodies at day 4.75 into populations that develop into distinct mesodermal lineages. Definitive hematopoietic potential was restricted to the Flk1+Podxl+ population, while the Flk1-negative Podxl+ population displayed only primitive erythroid potential. The Flk1+Podxl-negative population contained endothelial cells and cardiomyocyte potential. Podxl expression distinguishes Flk1+ mesoderm populations in mouse embryos at days 7.5, 8.5, and 9.5 and is a marker of progenitor stage primitive erythroblasts. These findings identify Podxl as a useful tool for separating distinct mesodermal lineages. Stem Cells 2014;32:191–203
- 1 December 2013
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 51 (4) , 213-219
Erythroid development in the mammalian embryo
- 1 December 2013
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 51 (4) , 213-219
Erythroid development in the mammalian embryo
Analysis of primitive erythroid cell proliferation and enucleation using a cyan fluorescent reporter in transgenic mice
Primitive erythropoiesis is a vital process for mammalian embryonic development. Here we report the generation and characterization of a new transgenic mouse line that expresses a histone H2B-CFP fusion protein in the nuclei of primitive erythroid cells. We demonstrate the potential of this ε-globin-histone H2B-CFP line for multicolor imaging and flow cytometry analysis. The ε-globin-H2B-CFP line was used to analyze the cell cycle distribution and proliferation of CFP-expressing primitive erythroblasts from E8.5-E13.5. We also evaluated phagocytosis of extruded CFP-positive nuclei by macrophages in fetal liver and placenta. The ε-globin-H2B-CFP transgenic mouse line adds to the available tools for studying the development of the primitive erythroid lineage.
Analysis of primitive erythroid cell proliferation and enucleation using a cyan fluorescent reporter in transgenic mice
Primitive erythropoiesis is a vital process for mammalian embryonic development. Here we report the generation and characterization of a new transgenic mouse line that expresses a histone H2B-CFP fusion protein in the nuclei of primitive erythroid cells. We demonstrate the potential of this ε-globin-histone H2B-CFP line for multicolor imaging and flow cytometry analysis. The ε-globin-H2B-CFP line was used to analyze the cell cycle distribution and proliferation of CFP-expressing primitive erythroblasts from E8.5-E13.5. We also evaluated phagocytosis of extruded CFP-positive nuclei by macrophages in fetal liver and placenta. The ε-globin-H2B-CFP transgenic mouse line adds to the available tools for studying the development of the primitive erythroid lineage.